These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 38155994)
1. Trazodone in the Management of Major Depression Among Elderly Patients with Dementia: A Narrative Review and Clinical Insights. Fagiolini A; González Pinto A; Miskowiak KW; Morgado P; Young AH; Vieta E Neuropsychiatr Dis Treat; 2023; 19():2817-2831. PubMed ID: 38155994 [TBL] [Abstract][Full Text] [Related]
3. Role of trazodone in treatment of major depressive disorder: an update. Fagiolini A; González-Pinto A; Miskowiak KW; Morgado P; Young AH; Vieta E Ann Gen Psychiatry; 2023 Sep; 22(1):32. PubMed ID: 37660092 [TBL] [Abstract][Full Text] [Related]
4. Clinical guidance for the use of trazodone in major depressive disorder and concomitant conditions: pharmacology and clinical practice. Cuomo A; Ballerini A; Bruni AC; Decina P; Di Sciascio G; Fiorentini A; Scaglione F; Vampini C; Fagiolini A Riv Psichiatr; 2019; 54(4):137-149. PubMed ID: 31379379 [TBL] [Abstract][Full Text] [Related]
5. Rethinking the role of trazodone in the different depressive dimensions. Berardelli I; Amerio A; Bartoli F; Cuomo A; Deste G; Orsolini L; Sampogna G; Pompili M Expert Rev Neurother; 2024 Jul; 24(7):619-632. PubMed ID: 38881379 [TBL] [Abstract][Full Text] [Related]
6. [Current treatment of depression and agitation in the elderly -- clinical use of trazodone]. Osváth P Neuropsychopharmacol Hung; 2013 Sep; 15(3):147-55. PubMed ID: 24108179 [TBL] [Abstract][Full Text] [Related]
7. Antidepressants for agitation and psychosis in dementia. Seitz DP; Adunuri N; Gill SS; Gruneir A; Herrmann N; Rochon P Cochrane Database Syst Rev; 2011 Feb; (2):CD008191. PubMed ID: 21328305 [TBL] [Abstract][Full Text] [Related]
8. Considerations and Current Trends in the Management of the Geriatric Patient on a Consultation-Liaison Service. Glass OM; Hermida AP; Hershenberg R; Schwartz AC Curr Psychiatry Rep; 2020 Apr; 22(5):21. PubMed ID: 32285305 [TBL] [Abstract][Full Text] [Related]
9. TED-trazodone effectiveness in depression: a naturalistic study of the effeciveness of trazodone in extended release formulation compared to SSRIs in patients with a major depressive disorder. Dudek D; Chrobak AA; Krupa AJ; Gorostowicz A; Gerlich A; Juryk A; Siwek M Front Pharmacol; 2023; 14():1296639. PubMed ID: 38027034 [No Abstract] [Full Text] [Related]
10. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder. Sheehan DV; Rozova A; Gossen ER; Gibertini M Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790 [TBL] [Abstract][Full Text] [Related]
11. [Personalized treatment of depression phenotypes: role of trazodone in depression with insomnia]. Antonelli Incalzi R; Caraci F; Cuomo A; Fagiolini A; Ferini Strambi L Riv Psichiatr; 2020; 55(6):371-379. PubMed ID: 33349731 [TBL] [Abstract][Full Text] [Related]
12. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics. Maher AR; Theodore G J Manag Care Pharm; 2012 Jun; 18(5 Suppl B):S1-20. PubMed ID: 22784311 [TBL] [Abstract][Full Text] [Related]
13. Clinical profile of trazodone users in a multisetting older population: data from the Italian GeroCovid Observational study. Coin A; Noale M; Gareri P; Trevisan C; Bellio A; Fini F; Abbatecola AM; Del Signore S; Malara A; Mossello E; Fumagalli S; Volpato S; Monzani F; Bellelli G; Zia G; Incalzi RA; Eur Geriatr Med; 2023 Jun; 14(3):465-476. PubMed ID: 37204681 [TBL] [Abstract][Full Text] [Related]
14. [Serotonin neurotrasmission and treatment options for depression]. Sivolap YP Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):174-177. PubMed ID: 29265105 [TBL] [Abstract][Full Text] [Related]
15. [Personalized medicine with extended-release trazodone and/or once-a-day trazodone: from research trials to clinical practice]. Cuomo A; Fiorentini A; Vampini C; Fagiolini A Riv Psichiatr; 2020; 55(5):255-261. PubMed ID: 33078017 [TBL] [Abstract][Full Text] [Related]
16. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary. Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561 [TBL] [Abstract][Full Text] [Related]
17. [Trazodone--its multifunctional mechanism of action and clinical use]. Frecska E Neuropsychopharmacol Hung; 2010 Dec; 12(4):477-82. PubMed ID: 21220793 [TBL] [Abstract][Full Text] [Related]
18. Trazodone for agitation in dementia. Martinon-Torres G; Fioravanti M; Grimley EJ Cochrane Database Syst Rev; 2004 Oct; (4):CD004990. PubMed ID: 15495135 [TBL] [Abstract][Full Text] [Related]
19. Jitteriness/anxiety syndrome caused by coadministration of celecoxib, a selective COX-2 inhibitor, with escitalopram and trazodone in a patient with depression and spondylolisthesis. Shirata T; Yano S; Noto K; Kanno M; Suzuki A Neuropsychopharmacol Rep; 2023 Jun; 43(2):264-266. PubMed ID: 36847164 [TBL] [Abstract][Full Text] [Related]
20. Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders. Haria M; Fitton A; McTavish D Drugs Aging; 1994 Apr; 4(4):331-55. PubMed ID: 8019056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]